Denali Growth Partners
Overview
Denali Growth Partners (DGP) is a Boston-based growth equity firm that partners with growing, profitable, and capital-efficient companies. The firm's investment focus includes healthcare, life sciences, professional services, technology-enabled platforms, and software.
Portfolio Companies
6
Website
denaligrowth.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| HiLabs | Mar 2024 | Series B | Lead |
| Sollis Health | Jan 2022 | Series A | Lead |
| Luxonis | Jun 2026 | Series A | Lead |
| SlipStream I.T. Inc. | Aug 2025 | Private Equity | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Denali Growth Partners based?
Denali Growth Partners is headquartered in Boston, Massachusetts, United States.
When was Denali Growth Partners founded?
Founding year information for Denali Growth Partners is not publicly available.
How many portfolio companies does Denali Growth Partners have?
Denali Growth Partners has 6 portfolio companies in Caplight's dataset.
What are some companies in Denali Growth Partners's portfolio?
Portfolio companies visible on Caplight include HiLabs, Sollis Health, Luxonis, SlipStream I.T. Inc..
What was Denali Growth Partners's most recent investment shown here?
Denali Growth Partners's most recent investment in this portfolio sample was in Luxonis in 2026.
What sectors does Denali Growth Partners focus on?
Denali Growth Partners focuses on Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, FinTech.
What company stages does Denali Growth Partners focus on?
Denali Growth Partners typically invests at the Late stage.
What is Denali Growth Partners's AUM?
Denali Growth Partners's assets under management are estimated between $750.0M and $750.0M.